The Thaw
Mar27

The Thaw

This week’s announcement that Albany Molecular Research Inc. will acquire Cedarburg Hauser Pharmaceuticals—a $41 million deal—has us on the verge of declaring a trend. You will recall that last October, AAIPharma purchased another Midwest active pharmaceutical ingredients (API) producer, Cambridge Major Laboratories. All we need is one more to feel that the black ice of overcapacity in pharmaceutical fine chemicals is finally starting...

Read More
DCAT Week 2014
Mar14

DCAT Week 2014

Things could not have been more “up” at DCAT Week, the annual occupation of the Waldorf Astoria and environs by the Drug Chemicals and Allied Trades association that wrapped up last night. (Each March, DCAT hosts the largest black tie banquet of the year at the grand old hotel). Business in the pharmaceutical chemicals sector is up for the third year in a row, in fact, making for a kind of “up momentum”. While growth is not a major...

Read More
State of the Vibe
Jan26

State of the Vibe

I’ll share the gist of my Informex talk, which was entitled State of the Vibe in Pharma Chem or When New Worlds Collide. I spoke using PowerPoint slides, which I had never done before. Having seen hundreds of PowerPoint presentations, however, I knew that they had to begin with a “Forward-Looking Statement”, something to get the speaker or the speaker’s employer off the hook. So, I led the presentation with my own forward-looking...

Read More
C&EN Talks at Informex
Jan24

C&EN Talks at Informex

Informex, if somewhat downsized, was upbeat in Miami. I haven’t got official word from UBM on attendance, but the consensus on the exhibit floor was that floor walking was down. Business, however, was up! David Ager, principle scientist with DSM, said it was well worth the travel to South Beach for the leads his company picked up. Others said the same. Generally, spirits were higher in Miami than they were in Anaheim last year. Go...

Read More
Buh-buh-buh-buh-buh-Bad!
Jan22

Buh-buh-buh-buh-buh-Bad!

Today I was offered a great opportunity to air my grievances about Breaking Bad, the award-winning AMC dramatic series that I have avoided watching. As it turns out, I’m glad I waited until now! Donna Nelson, a chemistry professor at the University of Oklahoma who has garnered a bit of fame in the chemistry world as a consultant for the series, was the opening speaker at Informex this morning. I hit her with my reservations regarding...

Read More